Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes.

[1]  N. Terrault,et al.  The option of HBIG-free prophylaxis against recurrent HBV. , 2012, Journal of hepatology.

[2]  Gretchen A. Stevens,et al.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.

[3]  K. Waki,et al.  Outcome of Liver Transplantation for Recipients With Hepatitis B and Hepatitis C Virus Coinfection: Analysis of the UNOS Data , 2011, Transplantation.

[4]  A. Lok,et al.  Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. , 2010, Journal of hepatology.

[5]  E. Gane.  Posttransplant Prophylaxis Strategies for Hepatitis B , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  M. Manns,et al.  Managing HBV in patients with impaired immunity , 2010, Gut.

[7]  M. Colombo,et al.  A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. , 2009, Gastroenterology.

[8]  D. Samuel,et al.  Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation. , 2008, Gastroenterology.

[9]  J. Lewsey,et al.  Survival after liver transplantation in the United Kingdom and Ireland compared with the United States , 2007, Gut.

[10]  P. Pontisso,et al.  Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease. , 2006, World journal of gastroenterology.

[11]  C. Sabin,et al.  3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome , 2006, The Lancet.

[12]  A. Gurakar,et al.  Liver transplantation for hepatitis B in the United States. , 2005, Transplantation proceedings.

[13]  M. Rizzetto,et al.  Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  M. Rizzetto,et al.  Treatment of hepatitis D , 2005, Journal of viral hepatitis.

[15]  A. Gurakar,et al.  LIVER TRANSPLANTATION FOR HEPATITIS B IN USA: 212 , 2004 .

[16]  W. Kim,et al.  Outcome of liver transplantation for hepatitis B in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  Mark S Roberts,et al.  Survival after liver transplantation in the United States: A disease‐specific analysis of the UNOS database , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[18]  L. Grande,et al.  Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers , 2003, Transplantation.

[19]  E. Schiff,et al.  A multicenter United States—Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B , 2001, Hepatology.

[20]  P. Neuhaus,et al.  Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study , 2000, The Lancet.

[21]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[22]  G. Alexander,et al.  Liver transplantation in European patients with the hepatitis B surface antigen. , 1993, The New England journal of medicine.

[23]  P. Schemmer,et al.  Survival after liver transplantation in the United Kingdom and Ireland compared with the United States , 2007 .